跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DIOVAN 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DIOVAN 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
DIOVAN 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Novartis Farma S.P.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 8, 2023
Approval ID
ba8ba83dd9d08330
Company
Novartis Farma S.P.A.
Type
Standard
Approval Details
Approval Id
ba8ba83dd9d08330
Drug Cima Aemps Name
DIOVAN 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
033178942IP
Holder Company Name
Novartis Farma S.P.A.
Marketing Company Name
Ecofar Productos S.L.
Holder Company Detail Path
/organization/novartis-farma-spa
Authorization Date
2023-11-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
160 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Novartis Farma S.P.A.
Company Detail Path
/organization/novartis-farma-spa
Company Information
Pharmaceutical Company Name
NOVARTIS FARMA SPA
Country Name
Italy
City Name
torre annunziata,napoli,country_it
Address
VIA PROVINCIALE SCHITI 131
Active Ingredients
VALSARTAN
160 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 8, 2023
Approval ID
ba8ba83dd9d08330
Type
Standard
Back to CIMA-AEMPS Approvals
